Dr. Kevin Rurak, MD

Dr. Rurak practices at Saint Joseph Hospital in Denver, Colorado, part of Intermountain Health.

Dr. Rurak's NPI, 1154702751, was assigned on June 9, 2015. Dr. Rurak holds New York license 298948.

Dr. Rurak's primary practice is Saint Joseph Hospital, at 1375 E 19th Ave, Denver, CO 80218 in Denver County. The practice phone is (303) 812-2000.

Dr. Rurak's primary practice is Saint Joseph Hospital in Denver, Colorado, part of Intermountain Health. Dr. Rurak is also affiliated with National Jewish Health. The medical group on file is Mount Sinai Institute for Liver Medicine. Dmand AI also links Dr. Rurak to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rurak practices, 3 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Rurak's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dmand AI has Dr. Rurak's licenses on file in 2 states: New York and Pennsylvania.

CMS data shows 244 Medicare services from Dr. Rurak across 6 procedure codes in 2024, for 151 Medicare patients. Medicare paid $22,173 for them.

CMS counts 151 Medicare patients who saw Dr. Rurak in 2024. The largest group is 65 to 74, with 65 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 14% are also on Medicaid. Their average risk score is 1.98, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rurak's median patient age at 72, with 62% women.

In 2024, Dr. Rurak wrote 522 Medicare Part D claims for 127 patients. 39% of them were for generic drugs. CMS names the drug for 388 of them, across 10 drugs with 11 or more claims each, at $299,704 in total drug cost. In 2023, CMS named 706 claims across 16 drugs.

Dr. Rurak accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rurak as offering telehealth.

CMS Open Payments shows 14 general payments to Dr. Rurak from 7 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 87% of the total. Actelion Pharmaceuticals US, Inc. paid the most, $462.